Now I have all the information I need. Let me produce the consolidated review.

## Summary

This paper proposes DecompOpt, a structure-based molecular optimization method that combines a controllable decomposed diffusion model with iterative optimization. The key idea is to decompose ligands into arms and scaffold, maintain ordered arm lists for each subpocket, and iteratively generate new ligand molecules conditioned on top-ranked arms from previous rounds. This framework supports both *de novo* design and controllable generation tasks (R-group design, scaffold hopping). The paper reports state-of-the-art results on the CrossDocked2020 benchmark with a Vina Dock score of −8.98 and a multi-objective Success Rate of 52.5%, substantially outperforming the strongest generative baseline DecompDiff (−8.43, 34.5%) and the optimization baseline RGA (37.0%).

## Strengths

- **Novel combination of diffusion models with iterative optimization for 3D molecular design.** The closed-loop optimization where a conditional diffusion model generates ligands conditioned on top-ranked arms, arms are scored and used to update ordered arm lists, and the cycle repeats (Section 3.2) is a clear conceptual advance. The main results (Table 1) demonstrate its effectiveness: DecompOpt achieves substantially better Vina Dock (−8.98 vs. −8.43) and Success Rate (52.5% vs. 34.5%) than DecompDiff, the strongest diffusion baseline, while maintaining competitive diversity (0.769).

- **Principled decomposition enabling localized optimization and controllable generation.** The arm-level decomposition is not just a modeling choice but the workhorse of both optimization and controllability. The ablation (Table 2) directly validates that arm-wise optimization achieves better Vina Score (−8.59) and Success Rate (51.2%) than molecule-wise optimization (−8.28, 38.5%). The same decomposition naturally extends to R-group design and scaffold hopping by fixing or replacing specific substructures.

- **State-of-the-art de novo results on a standard benchmark.** On the CrossDocked2020 benchmark with 100 test proteins, DecompOpt achieves the best reported Vina Dock (−8.98), High Affinity (58.0%), and Success Rate (52.5%) among all compared methods, including both generative and optimization baselines. Single-objective experiments (Table 3) confirm that each targeted property (QED, SA, Vina Min) can be independently improved, and the diversity remains competitive with pure generative methods.

- **Ablation and analysis support the core claims.** The paper provides systematic ablation: arm-level vs. molecule-level optimization (Table 2), single-objective optimization (Table 3), and comparison against a controlled variant (TargetDiff w/ Opt.). These experiments strengthen the attribution of gains to the decomposed optimization framework rather than simply adding more compute.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

- **The training procedure for the conditional diffusion model is underspecified.** The paper describes the condition encoder and how arm conditions are injected into the reverse process (Section 3.1), and states that "the rest of the diffusion-based decoder mainly follows DecompDiff... including the decomposed prior distribution, model architecture, training loss, etc." (line 125). However, it never explicitly states what arm conditions are used **during training** — i.e., whether the model is trained in a self-supervised manner where each training ligand is decomposed and its own arms serve as conditions, or whether some cross-molecule conditioning augmentation is used. This detail matters because at inference time during optimization, arms come from different molecules (the ordered lists). While the natural reading is same-molecule self-supervision (standard for conditional models of this form), the paper should clarify this and ideally provide evidence (e.g., a simple experiment measuring validity when conditioning on cross-molecule arms) to confirm that the model generalizes to cross-molecule conditioning. This does not invalidate the results but is needed for reproducibility.

- **The controllable generation evaluation lacks quantitative comparison against existing specialized 3D methods.** The paper claims a "unified framework" and presents R-group design and scaffold hopping results, but the comparisons are limited to "diffusion inpainting" (i.e., ablations of the paper's own model without arm conditions). No numerical comparison is provided against established 3D controllable generation methods such as 3DLinker (Huang et al.) or DiffLinker (Igashov et al.), which are cited in Related Work but not benchmarked against. For scaffold hopping, the paper follows the evaluation protocol from 3DLinker but does not report 3DLinker's numbers. Given that the paper's primary contribution is *de novo* optimization, this is not a fatal flaw, but it weakens the claim of a "unified framework" that surpasses specialized methods. The paper would benefit from either adding these comparisons or tempering the claim.

- **The ligand decomposition algorithm (into arms and scaffold) is not fully specified.** While the paper states that "a ligand molecule can be naturally decomposed into several components" (line 104) and references DecompDiff, it does not describe the exact rule for how the decomposition is performed (e.g., how bond cuts are chosen, how arms are assigned to subpockets). Since the decomposition is central to both the conditional model and the optimization loop, this missing detail reduces reproducibility. The paper should at minimum cite the specific decomposition procedure from DecompDiff or describe it briefly.

### Trivial

- The re-docking step for new arms (Section 3.2) is described as "optional" but never ablated — its contribution to the overall result is unknown. A brief ablation would be informative but is not critical.

- The paper does not report the computational cost (number of oracle calls, inference time per molecule, model parameters), which would help assess practical applicability. This is a minor omission.

- The Z-score aggregation for multi-objective optimization uses equal weights with no sensitivity analysis. The paper acknowledges this as future work in the conclusion, so it is acceptable, but a brief discussion of weight sensitivity would strengthen the analysis.

## Nice-to-Haves

- A simple experiment validating the model's ability to handle cross-molecule arm conditioning (e.g., measure validity/completion rate when arms come from different source molecules) would directly address the training clarification question.
- For the controllable generation experiments, adding quantitative comparisons to 3DLinker or DiffLinker on the same metrics (Validity, Uniqueness, Novelty, Complete Rate) would substantially strengthen the "unified framework" claim.
- A Pareto-front or trade-off analysis for the multi-objective optimization would provide richer insight than the single aggregated Z-score.

## Removed Points

- **Criticism that tables are "not fully reproduced" or incomplete due to parser extraction:** The tables are included via `\input{}` commands in the original submission; the extracted plain text cannot render them. These are parser artifacts, not missing content. Removed per hard rule.
- **Formatting nitpicks about "\revise" tags and "}" remnants:** These are parser artifacts, not author errors. Removed per hard rule.
- **Criticism about RGA's QED/SA not being in Table 1:** The table is in a separate file; what is visible in the extracted text is incomplete. Removed per hard rule about parser artifacts.
- **Generic strengths from Strength Finder that are superficial or conflict with verified weaknesses:** None of the Strength Finder's claims were generic enough to remove.

## Novel Insights

None beyond the paper's own contributions. The reviews largely converge on the paper's strengths and identify the same missing details (training procedure, decomposition algorithm, controllable generation baselines). The core insight — that decomposed arm-level conditioning enables a natural optimization loop where arms evolve across generations — is well-articulated in the paper itself.

## Suggestions

1. **Clarify the training procedure.** Explicitly state: (a) what arms serve as conditions during training (same-molecule self-supervision or cross-molecule augmentation); (b) how the model is trained end-to-end (reference the training loss from DecompDiff and describe any modifications); (c) provide a small-scale experiment showing the model's validity when conditioned on arms from different molecules.

2. **Specify the decomposition algorithm.** Provide a clear description (or at minimum a precise citation to the decomposition rules in DecompDiff) of how a ligand is partitioned into scaffold and arms, including how bond cuts are made and how arms are assigned to subpockets.

3. **Either add controllable generation baselines or soften the claims.** The "unified framework" claim would be stronger with quantitative comparison to 3DLinker/DiffLinker on scaffold hopping metrics. If these comparisons are not feasible, reframe the controllable generation section as a demonstration of the framework's flexibility rather than a competitive evaluation.

4. **Add a brief ablation of the re-docking step** to clarify whether it contributes meaningfully to the results.

## Score and Decision

The paper presents a clear, well-motivated contribution with strong empirical results on the *de novo* optimization task. The weaknesses are about missing technical details and evaluation scope — they are addressable in a revision and do not undermine the core claims. The method is novel, the experiments are sound, and the results represent a tangible advance over prior work.

MY FINAL SCORE: <score>7.5</score>
MY FINAL DECISION: <decision>Accept</decision>